Recent insider trading activity from Bucher James B, including buys and sells reported to the SEC.
| Transaction Date | Company | Ticker | Insider Name | Title | Transaction Type | Security | Shares | Price | Shares Owned Following | Total Shares Outstanding | % of Owned | % of Outstanding |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Jan. 8, 2026 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Bucher James B | Chief Legal Officer | A | Stock Option (Right to Buy) | 100000 | $0.00 | 100,000.0000 | 72,250,779 | 9999.99% | 0.14% |
| Oct. 1, 2025 | Zentalis Pharmaceuticals, Inc. | $ZNTL | Bucher James B | Chief Legal Officer | A | Stock Option (Right to Buy) | 400000 | $0.00 | 400,000.0000 | 71,811,508 | 9999.99% | 0.56% |